Report post

What does bdtx stand for?

Find the latest Black Diamond Therapeutics, Inc. (BDTX) stock quote, history, news and other vital information to help you with your stock trading and investing.

What is bdtx-1535?

About BDTX-1535 BDTX-1535 is an oral, brain-penetrant MasterKey inhibitor of oncogenic epidermal growth factor receptor (EGFR) mutation in non-small cell lung cancer (NSCLC), including families of non-classical driver mutations (e.g., L747P, L718Q), acquired resistance C797S mutation, and complex mutations.

What is bdtx-4933 & bdtx-4876?

It is also developing BDTX-4933, a brain-penetrant RAF MasterKey inhibitor targeting KRAS, NRAS, and BRAF alterations in solid tumors that is in phase 1 clinical trial. In addition, the company is developing BDTX-4876, a MasterKey inhibitor of oncogenic FGFR2/3 mutations with selectivity versus FGFR1/4, which is in preclinical stage.

The World's Leading Crypto Trading Platform

Get my welcome gifts